Celyad retains Piper Jaffray & Co. to explore strategic alternatives relating to its C-Cure® cardiovascular assets

An exclusive mandate was given to Piper Jaffray, a well reputated international investment bank and asset management firm, to support the company in the partnering and/or the externalization of C-Cure^®.